Deals are often priced on a synergy story: “20% cost takeout,” “cross-sell into our base,” “shared GTM.” Synergy due diligence is the work that decides whether those dollars survive contact with org charts, systems, contracts, and customers. It is not the same as commercial due diligence (market and win rates), quality of earnings (earnings quality), or post-merger integration diligence (Day-1 and 100-day delivery). Synergy diligence underwrites the bridge from stand-alone to combined economics.
| Workstream | Primary question | Typical output |
|---|---|---|
| Commercial DD | Is the market and competitive position real? | Share, win/loss, pricing power |
| Synergy DD | Which combined dollars are real, when, and at what cost? | Cost/revenue bridges, CTA, risk cases |
| PMI / integration DD | Can we execute Day-1 and the plan without breaking the business? | Cutover, IMO, 100-day roadmap |
| QoE / financial DD | Are stand-alone earnings and cash quality clean? | Adjusted EBITDA, WC, debt-like items |
Build a complete inventory by type: cost (SG&A, procurement, manufacturing, facilities, IT/licenses), revenue (cross-sell, upsell, pricing, channel, geographic), capital (capex avoidance, inventory, WC), and tax/structure. Tag each line to a deal thesis (platform scale, bolt-on, vertical integration, geographic fill). Reject vague buckets with no owner or mechanism. Separate “already in the base case” from true combination value so you do not double-count growth that management would have delivered alone.
Lock the stand-alone cost and revenue baselines used in the bridge. Align charts of accounts, allocations, shared services, and one-time items. Test whether target “run-rate” savings were already booked pre-close. For multi-entity or carve-out deals, map stranded costs and TSA economics so synergy is not confused with stand-up cost. Document currency, fiscal calendar, and volume assumptions that drive the bridge.
Every synergy has a cost-to-achieve (CTA): severance and notice, dual-run systems, consultants, retention, facility exit, rebranding, contract buyouts, training. Phasing matters as much as the end-state: year-1 cash can be negative even when steady-state EBITDA looks strong. Build a quarterly cash view of CTA vs run-rate benefit. Flag savings that require capital projects or system cutovers that historically slip.
Revenue synergies fail more often than cost takeout. Demand customer-level proof: which products, which segments, which channel capacity, what price/volume trade-offs, and what churn risk from forced bundling. Stress-test sales capacity, commission plans, brand conflict, and competitive response. For add-on / bolt-on deals, separate true cross-sell from simple pro-forma aggregation of two pipelines.
Synergies are blocked by dependencies: key employees who own the savings plan, ERP or CRM that cannot consolidate on the timeline, change-of-control clauses, customer consent, union rules, license transfer, data residency, and brand restrictions. Map each material synergy line to its critical path dependencies and kill criteria. Tie people risk to people diligence and systems risk to technology diligence.
Define owners, KPIs, and a tracking cadence before close (IMO / value-creation office). Model dis-synergies explicitly: customer loss from integration noise, productivity dips, dual brand confusion, supplier price resets, talent flight. Run downside and base cases with different realization rates and delays. Align earnout or management incentive metrics with the same definitions used in diligence so SPA design does not fight the plan (see earnout diligence).
DI20-WELCOME) — useful for triage, not a full synergy audit or PMI design.
| Stage | Synergy focus | Buyer action |
|---|---|---|
| Pre-LOI / IOI | Top-down buckets, peer benchmarks, obvious overlaps | Price only what you can defend; flag CTA ranges |
| LOI / exclusivity | Bottom-up cost centers; early revenue hypotheses | Data request list; owner nominations; CTA draft |
| Confirmatory DD | Line-item bridges, systems timeline, customer proof | Red/amber/green by line; model cases; kill criteria |
| SPA / financing | Reps, earnout metrics, MAC/integration covenants | Align definitions; financing model matches diligence |
| Close / Day-1 | Tracking board live; dual-run plan funded | IMO cadence; no silent re-baselining |
| Signal | Severity | Why it matters |
|---|---|---|
| Synergies = % of cost with no line items | Deal-Killer | Cannot underwrite or track; often double-counted |
| Revenue synergies >50% of total value, no customer proof | Deal-Killer | Model equity value rests on hope |
| CTA missing or “in OpEx later” | High | Year-1 cash and covenant risk understated |
| Year-1 full run-rate on complex systems cutover | High | Historically slips 12–24 months |
| Same savings claimed in stand-alone plan and synergy case | High | Double-count destroys incremental value |
| Key synergy owner is a flight risk or contractor | High | Execution single point of failure |
| No dis-synergy case (churn, dual brand, supplier reset) | Watch | Asymmetric risk not priced |
| Earnout metrics conflict with synergy plan | Watch | Incentives fight integration |
| Approach | Typical cost | Timeline | Best use |
|---|---|---|---|
| Full synergy + PMI design | $30K–$200K+ | 3–10 weeks | Signed exclusivity, IC-grade value case |
| Boutique cost takeout rebuild only | $20K–$80K | 2–5 weeks | Clear cost overlap, limited revenue claims |
| Public first-pass risk pack | $49 | Minutes to hours | Triage before LOI / shortlist |
Before LOI, buyers use structured public research to pressure-test whether a combination story is even plausible: product and footprint overlap, headcount and location signals, customer logos, pricing, competitive density, and capital history. After LOI, the same hypotheses drive the data-room request list — cost-center detail, org charts, systems landscape, top-customer plans — so advisors do not waste weeks on empty synergy buckets. The pack is screening research, not a substitute for bottom-up bridges or integration design.
⇧ Already delivered: Tesla (TSLA) · Alphabet (GOOGL) · Palantir (PLTR) — real orders, real SEC data, every claim source-cited.
Get a structured first-pass diligence pack on your target — useful input for synergy and combination hypotheses, not a full synergy audit or PMI blueprint.
Order report $39.20 → Free brief Sample PDF